Singulus Technologies Aktiengesellschaft: SINGULUS TECHNOLOGIES Receives Low Double-Digit Million Follow-Up Order for Medical Technology

Kahl am Main (pta012/22.04.2021/09:10 UTC+2)

Disclosure of Insider Information Pursuant to Art. 17 MAR

SINGULUS TECHNOLOGIES Receives Low Double-Digit Million Follow-Up Order for Medical Technology

Kahl am Main, April 22, 2021 - The SINGULUS TECHNOLOGIES AG (SINGULUS TECHNOLOGIES) has received a follow-up order for the delivery of several processing machines from an internationally operating company in the medical sector. The machines of the MEDLINE type are intended for the extraction and coating of contact lenses. The order volume is in the low double-digit million Euro range. The prepayment for this order is expected to be received shortly.

The processing machine "MEDLINE Clean" cleans contact lenses from residues and subsequently coats the lenses in the course of an additional processing step. 

SINGULUS TECHNOLOGIES AG, Hanauer Landstrasse 103, 
D-63796 Kahl/Main, WKN A1681X / ISIN DE000A1681X5

Contact: 

Maren Schuster, Investor Relations, Tel.: + 49 (0) 160 9609 0279

Bernhard Krause, Corporate Communications, Tel.: +49 (0) 172 833 2224

Email: bernhard.krause@singulus.de

(end)

Emitter:	Singulus Technologies Aktiengesellschaft Hanauer Landstraße 103 63796 Kahl am Main Germany
Contact Person:	Bernhard Krause
Phone:	+49 170 9202924
E-Mail:	bernhard.krause@singulus.de
Website:	www.singulus.de
ISIN(s):	DE000A1681X5 (Share) DE000A2AA5H5 (Bond)
Stock Exchange(s):	Regulated Market in Berlin, Frankfurt; Free Market in Dusseldorf, Hamburg, Hannover, Munich, Stuttgart, Tradegate